Cargando…
Investigating the Genomic Background of CRISPR-Cas Genomes for CRISPR-Based Antimicrobials
CRISPR-Cas systems are an adaptive immunity that protects prokaryotes against foreign genetic elements. Genetic templates acquired during past infection events enable DNA-interacting enzymes to recognize foreign DNA for destruction. Due to the programmability and specificity of these genetic templat...
Autor principal: | Shim, Hyunjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185011/ https://www.ncbi.nlm.nih.gov/pubmed/35692726 http://dx.doi.org/10.1177/11769343221103887 |
Ejemplares similares
-
In silico optimization of RNA–protein interactions for CRISPR-Cas13-based antimicrobials
por: Park, Ho-min, et al.
Publicado: (2022) -
CrisprGE: a central hub of CRISPR/Cas-based genome editing
por: Kaur, Karambir, et al.
Publicado: (2015) -
Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects
por: Li, Yingjun, et al.
Publicado: (2019) -
CRISPR-Cas Genome Surgery in Ophthalmology
por: DiCarlo, James E., et al.
Publicado: (2017) -
CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)